Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Boulenger, J.-P.
Huusom, A. K. T.
Florea, I.
Bækdal, T.
and
Sarchiapone, M.
2006.
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
Current Medical Research and Opinion,
Vol. 22,
Issue. 7,
p.
1331.
Boulenger, J.-P.
2007.
Traitements antidépresseurs : critères d’évaluation du résultat thérapeutique.
L'Encéphale,
Vol. 33,
Issue. 4,
p.
666.
Corcoran, Ciaran
and
McAllister-Williams, R Hamish
2007.
Maximizing treatment outcomes in the depressed patient.
British Journal of Hospital Medicine,
Vol. 68,
Issue. 7,
p.
373.
Dombrovski, Alexandre Y.
Mulsant, Benoit H.
Houck, Patricia R.
Mazumdar, Sati
Lenze, Eric J.
Andreescu, Carmen
Cyranowski, Jill M.
and
Reynolds, Charles F.
2007.
Residual symptoms and recurrence during maintenance treatment of late-life depression.
Journal of Affective Disorders,
Vol. 103,
Issue. 1-3,
p.
77.
Johnson, Daniel A.
Grant, Emma J.
Ingram, Colin D.
and
Gartside, Sarah E.
2007.
Glucocorticoid Receptor Antagonists Hasten and Augment Neurochemical Responses to a Selective Serotonin Reuptake Inhibitor Antidepressant.
Biological Psychiatry,
Vol. 62,
Issue. 11,
p.
1228.
Viinamäki, Heimo
Hintikka, Jukka
Tolmunen, Tommi
Honkalampi, Kirsi
Haatainen, Kaisa
and
Koivumaa-Honkanen, Heli
2008.
Partial remission indicates poor functioning and a high level of psychiatric symptoms: A 3-phase 6-year follow-up study on major depression.
Nordic Journal of Psychiatry,
Vol. 62,
Issue. 6,
p.
437.
Bertschy, G.
2009.
Dépressions sévères : récurrence et chronicité.
L'Encéphale,
Vol. 35,
Issue. ,
p.
S257.
Kasper, Siegfried
Baldwin, David S.
Larsson Lönn, Sara
and
Boulenger, Jean-Philippe
2009.
Superiority of escitalopram to paroxetine in the treatment of depression.
European Neuropsychopharmacology,
Vol. 19,
Issue. 4,
p.
229.
Johnson, Daniel Anthony
Ingram, Colin David
Grant, Emma Jane
Craighead, Mark
and
Gartside, Sarah Elizabeth
2009.
Glucocorticoid Receptor Antagonism Augments Fluoxetine-Induced Downregulation of the 5-HT Transporter.
Neuropsychopharmacology,
Vol. 34,
Issue. 2,
p.
399.
Pelissolo, Antoine
2009.
Douleurs corporelles dans la dépression : prévalence et importance clinique.
La Presse Médicale,
Vol. 38,
Issue. 3,
p.
385.
Bertschy, G.
Haffen, E.
Gervasoni, N.
Gex-Fabry, M.
Osiek, C.
Marra, D.
Aubry, J.-M.
and
Bondolfi, G.
2010.
Self-rated residual symptoms do not predict 1-year recurrence of depression.
European Psychiatry,
Vol. 25,
Issue. 1,
p.
52.
Israel, Joshua A.
2010.
The Impact of Residual Symptoms in Major Depression.
Pharmaceuticals,
Vol. 3,
Issue. 8,
p.
2426.
Roca, Miquel
García-Toro, Mauro
García-Campayo, Javier
Vives, Margalida
Armengol, Silvia
García-García, Margarita
Asensio, David
and
Gili, Margalida
2011.
Clinical differences between early and late remission in depressive patients.
Journal of Affective Disorders,
Vol. 134,
Issue. 1-3,
p.
235.
Favré, P.
2012.
Efficacité clinique et obtention d’une rémission complète dans la dépression : intérêt de l’escitalopram.
L'Encéphale,
Vol. 38,
Issue. 1,
p.
86.
Godard, Julie
Baruch, Philippe
Grondin, Simon
and
Lafleur, Martin F.
2012.
Psychosocial and neurocognitive functioning in unipolar and bipolar depression: A 12-month prospective study.
Psychiatry Research,
Vol. 196,
Issue. 1,
p.
145.
Ionescu, Dawn F.
Rosenbaum, Jerrold F.
and
Alpert, Jonathan E.
2015.
Pharmacological approaches to the challenge of treatment-resistant depression.
Dialogues in Clinical Neuroscience,
Vol. 17,
Issue. 2,
p.
111.
Boerema, A. M.
Cuijpers, P.
Beekman, A. T. F.
Hellenthal, A.
Voorrips, L.
and
van Straten, A.
2016.
Is duration of psychological treatment for depression related to return into treatment?.
Social Psychiatry and Psychiatric Epidemiology,
Vol. 51,
Issue. 11,
p.
1495.
Zhao, Na
Wang, Xiaohong
Wu, Wenyuan
Hu, Yongdong
Niu, Yajuan
Wang, Xueyi
Gao, Chengge
Zhang, Ning
Fang, Yiru
Huang, Jizhong
Liu, Tiebang
Jia, Fujun
Zhu, Xuequan
Hu, Jian
and
Wang, Gang
2017.
Gender differences in quality of life and functional disability for depression outpatients with or without residual symptoms after acute phase treatment in China.
Journal of Affective Disorders,
Vol. 219,
Issue. ,
p.
141.
Park, Sol A
Jeon, Sang Won
Yoon, Ho-Kyoung
Yoon, Seo Young
Shin, Cheolmin
and
Ko, Young-Hoon
2018.
Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale.
Psychiatry Investigation,
Vol. 15,
Issue. 2,
p.
178.
Bobes, Julio
Saiz-Ruiz, Jerónimo
and
Pérez, Víctor
2019.
Barriers to complete recovery of major depression: Cross-sectional, multi-centre study on clinical practice. RECORD study.
Revista de Psiquiatría y Salud Mental (English Edition),
Vol. 12,
Issue. 3,
p.
141.
Comments
No Comments have been published for this article.